clinical medicine
3,770 projects
oncology1,857cardiology336endocrinology314psychiatry250embryology236surgery212physiotherapy149obstetrics142pneumology137ophthalmology122transplantation119gastroenterology94angiology69rheumatology67allergology60hepatology59nephrology51radiology36hematology28critical care medicine19gynaecology19odontology16otorhinolaryngology15orthopaedics13
HEIndividual fellowship2025–2026Italy
GBM4EPI · Development of glioblastoma and blood-tumour barrier models for investigating the combination therapy of anticancer agents and efflux pump inhibitors
HEIndividual fellowship2025–2027Germany
UBImmune · Identification of novel therapeutic approaches to target the immune checkpoint protein B7H3
HEIndividual fellowship2025–2028Spain
GLUCHIRAL · Molecular chirality tools for the study of Gluten Immunogenic Peptides and Celiac Disease: Novel therapeutic and diagnostic approaches.
2 partners
HEIndividual fellowship2025–2027France
TE-Time · Dissecting host-transposon interactions during germline development and their impact on genome integrity
HEIndividual fellowship2025–2026Spain
mirADAM · Blood microRNAs ADAM10-target: novel diagnostic and prognostic biomarkers for Alzheimer's disease by electrochemical sensors
HEIndividual fellowship2025–2027Sweden
HISTORABLE · Unveiling the role of histone marks in metabolic memory storage and transmission.
HEIndividual fellowship2025–2027France
DroneMTB · Directed and Responsive Oncology Nanoparticle-releasing microrobots from Engineered MagnetoTactic Bacteria
HEIndividual fellowship2025–2027Spain
EvoThalamus · Molecular and neurogenic evolution of the thalamus
HEIndividual fellowship2025–2027Luxembourg
HifCAT · HIF-1α in Cancer-Associated Fibroblasts: Unveiling implications for the tumor microenvironment and therapeutic strategies
2 partners · 2 countries
HEIndividual fellowship2025–2027Spain
DEXTER · Development of EXtracellular-based artificial bio-nanoparticles: a novel Targeted vector with high potential in cancer ThERapy
HEIndividual fellowship2025–2027Spain
CARLY · Development and characterization of a novel CAR T-cell therapy for NHL
2 partners
HEIndividual fellowship2025–2027Sweden
IN-FACT · INitiation FActor 3 as target in Cancer Therapy
2 partners · 2 countries
HEIndividual fellowship2025–2027Denmark
NanoACATre · Rational Design of ACAT Single Enzyme Nanogels for Hepatic Fibrosis Treatment-NanoACATre
HEIndividual fellowship2025–2028Sweden
MyReL · Reducing myopia progression with red light therapy: Treatment mechanisms and safety levels.
2 partners · 2 countries
HEIndividual fellowship2025–2027Spain
OikoDefensome · Uncovering the Defensome genetic toolkit of marine embryos in the context of climate change
2 partners · 2 countries
HEIndividual fellowship2025–2027Belgium
noCOLDmore · Reprogramming eNdOthelial cells in immune-COLD tuMORs
2 partners · 2 countries
HEIndividual fellowship2025–2027Belgium
DETECTIVE · DEmystifying Targets in Endothelial Cells for anti-Tumor Immunity improVEments
HEIndividual fellowship2025–2026Austria
PROSPER · Promoting RObust Systems biology on Patients and Experimental models with obesity-driven liveR cancer
HEIndividual fellowship2024–2027Belgium
DENOVO · Towards an Integrative Model of the Relationship Between Episodic Memory and Novelty Detection Through a Behavioural and Neuropsychological Approach
2 partners · 2 countries
HEStaff exchange2024–2028Netherlands
GRASSHOPPER · The GRASSHOPPER network: Jumping forward from preclinical development of pediatric cancer drugs to clinical implementation
18 partners · 16 countries
HEIndividual fellowship2024–2026Belgium
KetoFAPIs · Next generation ketoamide inhibitors of fibroblast activation protein (FAP) to revolutionize radionuclide therapy in cancer.
HEStaff exchange2024–2028Poland
PurHumanDrome · Disrupting purine de novo biosynthesis to fight cancer - from molecules to cells to in vivo studies.
5 partners · 5 countries
HEStaff exchange2024–2027Germany
GenDAI · Genomic applications for laboratory Diagnostics supported by Artificial Intelligence
6 partners · 3 countries
HEDoctoral network2024–2028Netherlands
Mac4Me · Macrophage Targets for Metastatic Treatment
26 partners · 13 countries
